Literature DB >> 9883805

Factor XI deficiency in women.

R A Kadir1, D L Economides, C A Lee.   

Abstract

Factor XI (FXI) deficiency is an uncommon autosomally transmitted coagulopathy found predominantly in Jewish kindreds. It is associated with variable bleeding tendency that usually manifests after trauma, surgery, or other challenges to hemostasis. Therefore, women with FXI deficiency are at risk of excessive bleeding during their menstrual periods, childbirth, and after surgery. Increased awareness and close collaboration among hematologists, obstetricians, and gynecologists and availability of management guidelines is essential to minimize these risks. This review provides data from current research in FXI deficiency and pregnancy care, menstrual problems, and the role of screening for this disorder in women referred with menorrhagia.

Entities:  

Mesh:

Year:  1999        PMID: 9883805     DOI: 10.1002/(sici)1096-8652(199901)60:1<48::aid-ajh8>3.0.co;2-q

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

Review 1.  Factor XI deficiency: About 20 cases and literature review.

Authors:  Yosra Dhaha; Wijdène El Borgi; Hajer Elmahmoudi; Mariem Achour; Sarra Fekih Salem; Fatma Ben Lakhal; Balkis Meddeb; Emna Gouider
Journal:  Tunis Med       Date:  2022 Janvier

2.  The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.

Authors:  Sarah Sharman Moser; Gabriel Chodick; Yan G Ni; Dan Chalothorn; Ming-Dauh Wang; Alan R Shuldiner; Lori Morton; Ophira Salomon; Jessica J Jalbert
Journal:  Thromb Haemost       Date:  2021-09-23       Impact factor: 6.681

Review 3.  Plasma contact factors as therapeutic targets.

Authors:  Benjamin F Tillman; Andras Gruber; Owen J T McCarty; David Gailani
Journal:  Blood Rev       Date:  2018-04-12       Impact factor: 8.250

4.  Uneventful cesarean delivery with administration of factor XI concentrate in a patient with severe factor XI deficiency.

Authors:  Georgios Mavromatidis; Konstantinos Dinas; Dimitrios Delkos; Fotios Goutzioulis; Christos Vosnakis; Emmanouel Hatzipantelis; Vassilia Garipidou; David Rousso
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

Review 5.  Why factor XI deficiency is a clinical concern.

Authors:  Allison P Wheeler; David Gailani
Journal:  Expert Rev Hematol       Date:  2016-06-24       Impact factor: 2.929

Review 6.  The rebirth of the contact pathway: a new therapeutic target.

Authors:  Priyanka Srivastava; David Gailani
Journal:  Curr Opin Hematol       Date:  2020-09       Impact factor: 3.218

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.